RayzeBio, Inc.
RYZBDelisted Feb 26, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001825367
RayzeBio, Inc. was delisted on Feb 26, 2024; its insiders filed their last Form 4 on Feb 28, 2024; 107 institutions reported holding it in 13F filings for Q4 2023, worth $3.40B in total; superinvestors Viking Global Investors and HHLR Advisors (Hillhouse) held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by RayzeBio, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for RayzeBio, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Viking Global Investors LP | 10% Owner | 0Indirect | Feb 28, 2024 | 0 |
| Halvorsen Ole Andreas | 10% Owner | 0Indirect | Feb 28, 2024 | 0 |
| Ott David C. | 10% Owner | 0Indirect | Feb 28, 2024 | 0 |
| Shabet Rose Sharon | 10% Owner | 0Indirect | Feb 28, 2024 | 0 |
| Viking Global Opportunities Parent GP LLC | 10% Owner | 0Indirect | Feb 28, 2024 | 0 |
| Viking Global Opportunities Drawdown Portfolio GP LLC | 10% Owner | 0Indirect | Feb 28, 2024 | 0 |
| Viking Global Opportunities Drawdown GP LLC | 10% Owner | 0Indirect | Feb 28, 2024 | 0 |
| Viking Global Opportunities Drawdown (Aggregator) LP | 10% Owner | 0Indirect | Feb 28, 2024 | 0 |
| Viking Global Opportunities Portfolio GP LLC | 10% Owner | 0Indirect | Feb 28, 2024 | 0 |
| Viking Global Opportunities GP LLC | 10% Owner | 0Indirect | Feb 28, 2024 | 0 |
| Viking Global Opportunities Illiquid Investments Sub-Master LP | 10% Owner | 0Indirect | Feb 28, 2024 | 0 |
| Tagliaferri Mary | Director | – | Feb 27, 2024 | 0 |
| Heyman Richard A. | Director | 0 | Feb 27, 2024 | 0 |
| Song Kenneth | PRESIDENT AND CHIEF EXECUTIVE | 0Indirect | Feb 27, 2024 | 0 |
| You Angie | Director | – | Feb 27, 2024 | 0 |
| Katabi Maha | Director | 0Indirect | Feb 27, 2024 | 0 |
| Larson Yi | Director | – | Feb 27, 2024 | 0 |
| Van Hauwermeiren Timothy | Director | – | Feb 27, 2024 | 0 |
| Oliger Christy J. | Director | – | Feb 27, 2024 | 0 |
| Moran Susan | CHIEF MEDICAL OFFICER | 0 | Feb 27, 2024 | 0 |
| Kush Arvind | CHIEF FINANCIAL OFFICER | 0 | Feb 27, 2024 | 0 |
| Redmile Group, LLC | 10% Owner | 1,857,706Indirect | Sep 21, 2023 | 0 |
| Green Jeremy | 10% Owner | 1,857,706Indirect | Sep 21, 2023 | 0 |
| Redmile Biopharma Investments II, L.P. | 10% Owner | 1,857,706Indirect | Sep 21, 2023 | 0 |
| Goodman Corey S | 10% Owner | 5,158,162 | Sep 21, 2023 | 0 |
| Adelman Robert J | 10% Owner | 5,158,162 | Sep 21, 2023 | 0 |
| venBio Global Strategic Fund III, L.P. | 10% Owner | 5,158,162 | Sep 21, 2023 | 0 |
| Venbio Global Strategic GP III, Ltd | 10% Owner | 5,158,162 | Sep 21, 2023 | 0 |
| Venbio Global Strategic GP III, L.P. | 10% Owner | 5,158,162 | Sep 21, 2023 | 0 |
| Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | 10% Owner | 1,557,846 | Sep 19, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 21, 2023 (view filing)5:00 PM ET | Sep 19 | 2 days | Viking Global Investors LP and 7 others10% Owner | PPurchase | +1.39M | $18.00 | +$25.0M | +391.6%1.74M after | 2 lotsDuplicate filing |
| Sep 21, 2023 (view filing)4:59 PM ET | Sep 19 | 2 days | Viking Global Investors LP and 7 others10% Owner | PPurchase | +1.39M | $18.00 | +$25.0M | +391.6%1.74M after | 2 lots |
| Sep 21, 2023 (view filing) | Sep 19 | 2 days | Katabi MahaDirector | PPurchase | +472.2K | $18.00 | +$8.50M | +64.0%1.21M after | 2 lots |